Aprepitant 40 MG Oral Capsule — RxCUI 644088
RxNorm drug concept · Semantic clinical drug
RxCUI 644088
Semantic clinical drug · SCD
● Current RxNorm concept 25 FDA products
36 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI644088
Official nameAprepitant 40 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped25
Package NDCs mapped36
Reported Medicaid activity (SDUD)17,014 prescriptions · 35 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Aprepitant: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Aprepitant is designed to prevent nausea and vomiting before they start — not to treat them once they've kicked in. It's given as part of a combination of anti-nausea medicines, us...
- What exactly is this medicine supposed to do for me?
- Not without a backup plan. Aprepitant can reduce how well hormonal birth control works — that includes the pill, the patch, implants, and some IUDs. This effect can last for a full...
- Can I take my birth control as usual while I'm on this?
🕸️ Concept Web — How Aprepitant 40 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Aprepitant 40 MG Oral Capsule
RxCUI 644088 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Aprepitant
358255IN
-
Aprepitant
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Emend
357280BN
-
Emend
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Aprepitant Oral Capsule
405798SCDF -
Aprepitant Oral Product
1157722SCDG -
Aprepitant Pill
1157723SCDG -
Aprepitant Oral Capsule [Emend]
406015SBDF -
Emend Oral Product
1175305SBDG -
Emend Pill
1175306SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Aprepitant Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Aprepitant 40 MG
644087SCDC -
Aprepitant 40 MG Oral Capsule [Emend]
644278SBD -
Aprepitant 40 MG [Emend]
644277SBDC
-
Aprepitant 40 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Aprepitant 40 MG
SCDC · 644087 -
Aprepitant Oral Capsule
SCDF · 405798 -
Aprepitant Oral Product
SCDG · 1157722 -
Aprepitant Pill
SCDG · 1157723
Brand-Name Concepts
-
Aprepitant 40 MG Oral Capsule [Emend]
SBD · 644278 -
Aprepitant 40 MG [Emend]
SBDC · 644277 -
Aprepitant Oral Capsule [Emend]
SBDF · 406015 -
Emend Oral Product
SBDG · 1175305 -
Emend Pill
SBDG · 1175306 -
Emend
BN · 357280
📦 FDA Products & Package NDCs
25 products · 36 package NDCs
36 package NDCs map to RxCUI 644088 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00006-0461-02 | 2 CAPSULE in 1 DOSE PACK (0006-0461-02) | EMEND | Merck Sharp & Dohme LLC | 2003-03-26 |
| 00006-0461-12 | 2 CAPSULE in 1 DOSE PACK (0006-0461-12) | EMEND | Merck Sharp & Dohme LLC | 2003-03-26 |
| 00006-3066-03 | 1 POUCH in 1 CARTON (0006-3066-03) / 1 POWDER, FOR SUSPENSI... | EMEND | Merck Sharp & Dohme LLC | 2015-12-17 |
| 00006-3862-03 | 1 KIT in 1 DOSE PACK (0006-3862-03) * 1 CAPSULE in 1 CAPSU... | EMEND | Merck Sharp & Dohme LLC | 2003-03-26 |
| 00006-3862-13 | 1 KIT in 1 DOSE PACK (0006-3862-13) * 1 CAPSULE in 1 CAPSU... | EMEND | Merck Sharp & Dohme LLC | 2003-03-26 |
| 00781-2321-06 | 1 BLISTER PACK in 1 CARTON (0781-2321-06) / 1 CAPSULE in 1... | Aprepitant | Sandoz Inc | 2016-12-27 |
| 00781-2321-51 | 5 BLISTER PACK in 1 CARTON (0781-2321-51) / 1 CAPSULE in 1... | Aprepitant | Sandoz Inc | 2016-12-27 |
| 00781-2322-46 | 2 CAPSULE in 1 DOSE PACK (0781-2322-46) | Aprepitant | Sandoz Inc | 2016-12-27 |
| 00781-2322-68 | 1 BLISTER PACK in 1 CARTON (0781-2322-68) / 6 CAPSULE in 1... | Aprepitant | Sandoz Inc | 2016-12-27 |
| 00781-2323-68 | 1 BLISTER PACK in 1 CARTON (0781-2323-68) / 6 CAPSULE in 1... | Aprepitant | Sandoz Inc | 2016-12-27 |
| 00781-4063-36 | 1 KIT in 1 DOSE PACK (0781-4063-36) * 1 CAPSULE in 1 BLIST... | Aprepitant | Sandoz Inc | 2016-12-27 |
| 13668-0591-81 | 1 BLISTER PACK in 1 CARTON (13668-591-81) / 1 CAPSULE in 1... | APREPITANT | Torrent Pharmaceuticals Limited | 2020-10-21 |
| 13668-0591-82 | 5 BLISTER PACK in 1 CARTON (13668-591-82) / 1 CAPSULE in 1... | APREPITANT | Torrent Pharmaceuticals Limited | 2020-10-21 |
| 13668-0592-84 | 2 BLISTER PACK in 1 CARTON (13668-592-84) / 1 CAPSULE in 1... | APREPITANT | Torrent Pharmaceuticals Limited | 2020-10-21 |
| 13668-0592-86 | 3 BLISTER PACK in 1 CARTON (13668-592-86) / 2 CAPSULE in 1... | APREPITANT | Torrent Pharmaceuticals Limited | 2020-10-21 |
| 13668-0593-86 | 6 BLISTER PACK in 1 CARTON (13668-593-86) / 1 CAPSULE in 1... | APREPITANT | Torrent Pharmaceuticals Limited | 2020-10-21 |
| 13668-0594-87 | 1 KIT in 1 DOSE PACK (13668-594-87) * 2 CAPSULE in 1 BLIST... | APREPITANT | Torrent Pharmaceuticals Limited | 2020-10-21 |
| 51407-0701-01 | 1 BLISTER PACK in 1 CARTON (51407-701-01) / 1 CAPSULE in 1... | APREPITANT | Golden State Medical Supply, Inc. | 2025-06-11 |
| 51407-0701-05 | 5 BLISTER PACK in 1 CARTON (51407-701-05) / 1 CAPSULE in 1... | APREPITANT | Golden State Medical Supply, Inc. | 2025-06-11 |
| 51407-0702-02 | 2 BLISTER PACK in 1 CARTON (51407-702-02) / 1 CAPSULE in 1... | APREPITANT | Golden State Medical Supply, Inc. | 2025-06-11 |
| 51407-0702-06 | 3 BLISTER PACK in 1 CARTON (51407-702-06) / 2 CAPSULE in 1... | APREPITANT | Golden State Medical Supply, Inc. | 2025-06-11 |
| 51407-0703-06 | 6 BLISTER PACK in 1 CARTON (51407-703-06) / 1 CAPSULE in 1... | APREPITANT | Golden State Medical Supply, Inc. | 2025-06-11 |
| 51407-0704-03 | 1 KIT in 1 DOSE PACK (51407-704-03) * 2 CAPSULE in 1 BLIST... | APREPITANT | Golden State Medical Supply, Inc. | 2025-06-11 |
| 68001-0666-01 | 1 BLISTER PACK in 1 CARTON (68001-666-01) / 1 CAPSULE in 1... | Aprepitant | BluePoint Laboratories | 2026-01-29 |
| 68001-0666-17 | 5 BLISTER PACK in 1 CARTON (68001-666-17) / 1 CAPSULE in 1... | Aprepitant | BluePoint Laboratories | 2026-02-02 |
| 68001-0667-01 | 2 CAPSULE in 1 DOSE PACK (68001-667-01) | Aprepitant | BluePoint Laboratories | 2026-02-02 |
| 68001-0667-19 | 1 BLISTER PACK in 1 CARTON (68001-667-19) / 6 CAPSULE in 1... | Aprepitant | BluePoint Laboratories | 2026-01-29 |
| 68001-0668-19 | 1 BLISTER PACK in 1 CARTON (68001-668-19) / 6 CAPSULE in 1... | Aprepitant | BluePoint Laboratories | 2026-02-10 |
| 68001-0669-15 | 1 KIT in 1 DOSE PACK (68001-669-15) * 2 CAPSULE in 1 BLIST... | Aprepitant | BluePoint Laboratories | 2026-02-03 |
| 68462-0112-33 | 1 KIT in 1 DOSE PACK (68462-112-33) * 2 CAPSULE in 1 BLIST... | Aprepitant | Glenmark Pharmaceuticals Inc., USA | 2017-10-12 |
| 68462-0583-11 | 1 BLISTER PACK in 1 CARTON (68462-583-11) / 10 CAPSULE in 1... | Aprepitant | Glenmark Pharmaceuticals Inc., USA | 2017-10-12 |
| 68462-0583-40 | 1 BLISTER PACK in 1 CARTON (68462-583-40) / 1 CAPSULE in 1... | Aprepitant | Glenmark Pharmaceuticals Inc., USA | 2017-10-12 |
| 68462-0583-85 | 5 BLISTER PACK in 1 CARTON (68462-583-85) / 1 CAPSULE in 1... | Aprepitant | Glenmark Pharmaceuticals Inc., USA | 2017-10-12 |
| 68462-0584-58 | 2 CAPSULE in 1 DOSE PACK (68462-584-58) | Aprepitant | Glenmark Pharmaceuticals Inc., USA | 2017-10-12 |
| 68462-0584-76 | 1 BLISTER PACK in 1 CARTON (68462-584-76) / 6 CAPSULE in 1... | Aprepitant | Glenmark Pharmaceuticals Inc., USA | 2017-10-12 |
| 68462-0585-76 | 1 BLISTER PACK in 1 CARTON (68462-585-76) / 6 CAPSULE in 1... | Aprepitant | Glenmark Pharmaceuticals Inc., USA | 2017-10-12 |
Observed labelers:
Glenmark Pharmaceuticals Inc., USA (7) ·
BluePoint Laboratories (6) ·
Golden State Medical Supply, Inc. (6) ·
Sandoz Inc (6) ·
Torrent Pharmaceuticals Limited (6) ·
Merck Sharp & Dohme LLC (5)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J8501 | Oral aprepitant | 27 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.